3.52
0.85%
-0.03
Handel nachbörslich:
3.52
Phio Pharmaceuticals Corp Aktie (PHIO) Neueste Nachrichten
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Wiarton Echo
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Owen Sound Sun Times
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Nanton News
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - High River Times
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Melfort Journal
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - StockTitan
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA - StockTitan
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA - Invezz
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA - Newsfile
Contrasting Clearmind Medicine (NASDAQ:CMND) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World
Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Devon Dispatch
Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Nanton News
Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - North Bay Nugget
Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Newsfile
Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Phio Pharmaceuticals (NASDAQ:PHIO) Trading Down 0.8% - Defense World
Phio Pharmaceuticals Corp. (NASDAQ:PHIO): Is Breakeven Near? - Simply Wall St
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Yahoo Finance
Phio Pharmaceuticals Corp.'s (NASDAQ:PHIO) Path To Profitability - Yahoo Finance
Retinoblastoma Treatment Market to Surpass $2 Billion in 2024, Exhibiting a CAGR of 5.5% - GlobeNewswire Inc.
Phio Pharmaceuticals (NASDAQ:PHIO) Posts Earnings Results, Beats Estimates By $0.97 EPS - Defense World
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update - Newsfile
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update - Quantisnow
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update - StockTitan
Short Interest in Phio Pharmaceuticals Corp. (NASDAQ:PHIO) Rises By 178.0% - Defense World
PHIO stock touches 52-week low at $2.4 amid market challenges - Investing.com
Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound - Markets Insider
Phio Pharmaceuticals Announces Exploratory Collaboration with a - Airdrie Echo
Phio Pharmaceuticals Announces Exploratory Collaboration with a - The Kingston Whig-Standard
Phio Pharmaceuticals Announces Exploratory Collaboration with a - Shoreline Beacon
Phio Pharmaceuticals Announces Exploratory Collaboration with a - Kirkland Lake Northern News
Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound - Newsfile
Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound - Quantisnow
Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound - StockTitan
Phio Pharmaceuticals appoints new CFO By Investing.com - Investing.com UK
Phio Pharmaceuticals Names New VP and CFO - TipRanks
Phio Pharmaceuticals Announces New Chief Financial Officer - Newsfile
Phio Pharmaceuticals Announces New Chief Financial Officer - Quantisnow
Phio stock hits 52-week low at $3.29 amid market challenges - Investing.com Canada
Phio stock hits 52-week low at $3.29 amid market challenges - Investing.com
Phio Pharmaceuticals regains Nasdaq compliance post-reverse split - Investing.com
Phio Pharmaceuticals regains Nasdaq compliance post-reverse split By Investing.com - Investing.com Canada
Phio Pharmaceuticals Corp (PHIO) Stock: A Year of Market Fluctuations - The InvestChronicle
Phio Pharmaceuticals announces reduced-price warrant exercise - Investing.com India
Phio Pharmaceuticals announces reduced-price warrant exercise - Investing.com
Phio Pharmaceuticals announces reduced-price warrant exercise By Investing.com - Investing.com UK
Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds - Newsfile
Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds - StockTitan
Phio Pharmaceuticals expands cancer trial to UPMC - Investing.com
Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762 - Kirkland Lake Northern News
Seagate stock target raised, maintains Neutral stance on financial performance By Investing.com - Investing.com UK
Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762 - Yahoo Finance
Phio Pharmaceuticals ends share purchase deal with Triton Funds By Investing.com - Investing.com India
Cathie Wood's ARK ETF adjusts portfolio with key stock trades on July 8 By Investing.com - Investing.com
Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds - Wetaskiwin Times Advertiser
PHIOPhio Pharmaceuticals Corp. Latest Stock News & Market Updates - StockTitan
Phio Pharmaceuticals Scraps Share Sale to Triton Funds - TipRanks
Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds - The Kingston Whig-Standard
Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds - Kirkland Lake Northern News
Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds - Newsfile
Balance Sheet Breakdown: Phio Pharmaceuticals Corp (PHIO)'s Debt-to-Equity and Long-Term Debt/Eq Ratios ... - The Dwinnex
Phio Pharmaceuticals Corp (PHIO) may enjoy gains as insiders got busy in the recent days – Knox Daily - Knox Daily
Phio Pharmaceuticals enacts reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):